# The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors

> **NCT02623036** · PHASE1 · UNKNOWN · sponsor: **Memorial Health University Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Hypertension, Resistant to Conventional Therapy

## Interventions

- **DRUG:** Equivalent dose enalapril
- **DRUG:** Equivalent dose lisinopril

## Key facts

- **NCT ID:** NCT02623036
- **Lead sponsor:** Memorial Health University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02623036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02623036, "The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02623036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*